HSBC Holdings’s Upstream Bio UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$432K Buy
81,500
+70,707
+655% +$463K ﹤0.01% 2341
2026
Q2
$77.6K Sell
10,793
-629,533
-98% -$5.27M ﹤0.01% 2829
2026
Q1
$5.76M Buy
+640,326
New +$11.5M ﹤0.01% 1125

Other funds holding UPB

HSBC Holdings's UPB Position: Q3 2026 in Review

HSBC Holdings increased its Upstream Bio (UPB) stake by 655% in Q3 2026, buying an estimated $463K and bringing the position to 81,500 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #2341.

HSBC Holdings first reported a position in UPB in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.76M in Q1 2026. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.

  • HSBC Holdings held 81,500 shares of Upstream Bio worth $432K as of Q3 2026.
  • HSBC Holdings bought 70,707 Upstream Bio shares in Q3 2026, an estimated $463K.
  • Upstream Bio made up ﹤0.01% of HSBC Holdings's portfolio in Q3 2026, its #2341 holding.
  • HSBC Holdings first reported a position in Upstream Bio in Q1 2026 and has held it in 3 quarters since.
  • HSBC Holdings's Upstream Bio position peaked at $5.76M in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.

Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.